Suppr超能文献

胆管癌的危险因素。

Risk factors for cholangiocarcinoma.

机构信息

Section of Gastroenterology at the Michael E. DeBakey Veterans Affairs Medical Center and Baylor College of Medicine, Houston, TX 77030, USA.

出版信息

Hepatology. 2011 Jul;54(1):173-84. doi: 10.1002/hep.24351.

Abstract

Cholangiocarcinoma (CC) is the second most common primary hepatic malignancy after hepatocellular cancer. CC accounts for approximately 10%-25% of all hepatobiliary malignancies. There are considerable geographic and demographic variations in the incidence of CC. There are several established risk factors for CC, including parasitic infections, primary sclerosing cholangitis, biliary-duct cysts, hepatolithiasis, and toxins. Other less-established potential risk factors include inflammatory bowel disease, hepatitis C virus, hepatitis B virus, cirrhosis, diabetes, obesity, alcohol drinking, tobacco smoking, and host genetic polymorphisms. In studies where the distinction between intra- and extrahepatic CC was used, some potential risk factors seem to have a differential effect on CC, depending on the site. Therefore, the consistent use of a more refined classification would allow a better understanding of risk factors for CC.

摘要

胆管癌(CC)是继肝细胞癌之后的第二大常见原发性肝恶性肿瘤。CC 约占所有肝胆恶性肿瘤的 10%-25%。CC 的发病率在地理和人口统计学上存在很大差异。有几个已确定的 CC 危险因素,包括寄生虫感染、原发性硬化性胆管炎、胆管囊肿、肝胆管结石和毒素。其他不太确定的潜在危险因素包括炎症性肠病、丙型肝炎病毒、乙型肝炎病毒、肝硬化、糖尿病、肥胖、饮酒、吸烟和宿主遗传多态性。在使用肝内和肝外 CC 区分的研究中,一些潜在的危险因素似乎对 CC 有不同的影响,这取决于部位。因此,更精细的分类的一致使用将有助于更好地了解 CC 的危险因素。

相似文献

1
Risk factors for cholangiocarcinoma.胆管癌的危险因素。
Hepatology. 2011 Jul;54(1):173-84. doi: 10.1002/hep.24351.
2
Risk factors for cholangiocarcinoma.胆管癌的危险因素。
Eur J Gastroenterol Hepatol. 2007 Aug;19(8):615-7. doi: 10.1097/MEG.0b013e328224b935.
3
Epidemiology of cholangiocarcinoma.胆管癌的流行病学
Best Pract Res Clin Gastroenterol. 2015 Apr;29(2):221-32. doi: 10.1016/j.bpg.2015.02.003. Epub 2015 Feb 16.
5
The epidemiology of cholangiocarcinoma.胆管癌的流行病学
Semin Liver Dis. 2004 May;24(2):115-25. doi: 10.1055/s-2004-828889.
6
Clinical presentation, risk factors and staging systems of cholangiocarcinoma.胆管癌的临床表现、危险因素及分期系统
Best Pract Res Clin Gastroenterol. 2015 Apr;29(2):245-52. doi: 10.1016/j.bpg.2015.02.001. Epub 2015 Feb 14.
10
New epidemiologic trends in cholangiocarcinoma.胆管癌的新流行病学趋势。
Clin Res Hepatol Gastroenterol. 2023 Nov;47(9):102223. doi: 10.1016/j.clinre.2023.102223. Epub 2023 Oct 4.

引用本文的文献

6
Occupational and Environmental Cholangiocarcinoma-Related Toxic Exposures.职业性和环境性与胆管癌相关的有毒暴露
GE Port J Gastroenterol. 2024 Nov 7;32(3):151-160. doi: 10.1159/000541868. eCollection 2025 Jun.
8
CLDN18.2: a potential nanotherapeutic target for cholangiocarcinoma.紧密连接蛋白18.2:胆管癌潜在的纳米治疗靶点
Front Pharmacol. 2025 Mar 26;16:1559558. doi: 10.3389/fphar.2025.1559558. eCollection 2025.

本文引用的文献

2
Descriptive epidemiology of cholangiocarcinoma and clonorchiasis in Korea.韩国胆管癌和华支睾吸虫病的描述性流行病学。
J Korean Med Sci. 2010 Jul;25(7):1011-6. doi: 10.3346/jkms.2010.25.7.1011. Epub 2010 Jun 17.
3
Management of congenital bile duct cysts.先天性胆管囊肿的处理。
Dig Surg. 2010;27(1):12-8. doi: 10.1159/000268109. Epub 2010 Apr 1.
4
Cholangiocarcinoma: update and future perspectives.胆管癌:最新进展与未来展望。
Dig Liver Dis. 2010 Apr;42(4):253-60. doi: 10.1016/j.dld.2009.12.008. Epub 2010 Jan 22.
9
High lifetime risk of cancer in primary sclerosing cholangitis.原发性硬化性胆管炎患者终生患癌风险高。
J Hepatol. 2009 Jan;50(1):158-64. doi: 10.1016/j.jhep.2008.08.013. Epub 2008 Oct 14.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验